RecruitingPHASE1, PHASE2NCT07327359

A Study to Evaluate Safety and Efficacy of OLX72021 in Healthy Males With Androgenetic Alopecia

Studying Alopecia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Olix Pharmaceuticals, Inc.
Intervention
OLX72021(drug)
Enrollment
158 enrolled
Eligibility
18-59 years · MALE
Timeline
20252027

Study locations (1)

Collaborators

Avance Clinical Pty Ltd.

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07327359 on ClinicalTrials.gov

Other trials for Alopecia

Additional recruiting or active studies for the same condition.

See all trials for Alopecia

← Back to all trials